Invest in Genmab (gmab)

Bitpanda makes it easy for you to invest in Genmab from as little as €1. Invest 24/7 with zero commissions and tight spreads.

*Bitpanda Stocks are contracts replicating an underlying stock or ETF.

Get started

Genmab

How to invest in Genmab

With Bitpanda, you can invest in Genmab easily, quickly and securely.
1

Sign up to Bitpanda

Create a Bitpanda account and confirm your email address.

2

Verify and deposit funds

Confirm your identity with one of our trusted verification partners and deposit funds.

3

Start investing in Genmab

You’re all set! Start investing with Bitpanda Stocks in Genmab and over 1,000 other digital assets.

About Genmab (GMAB)

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukeamia. The company was founded by Donald Lee Drakeman, Florian Schonharting and Jan G. J. van de Winkel in 1999 and is headquartered in Copenhagen, Denmark.

Analyst ratings

%

Buy

Hold

Sell

Based on analysts ratings

Buy

Hold

Sell

Genmab market stats

Market cap
Daily high
Daily low
Volatility (1M)
Net income
Dividend yield
P/E ratio
Dividend per share
Earnings per share
Revenue
* Bitpanda Stocks are contracts replicating an underlying stock or ETF.